[Studies with 3H-labeled methylhydrazine derivatives].
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000627:therapeutic use; D001646:Bile / Q000032:analysis; D002279:Carcinoma 256, Walker / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D005243:Feces / Q000032:analysis; D006834:Hydrazines / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D007275:Injections, Intravenous; D009928:Organ Specificity; D011877:Radionuclide Imaging; D051381:Rats; D014316:Tritium
D000970:Antineoplastic Agents; D006834:Hydrazines; D014316:Tritium
Untersuchungen mit 3H-markierten Methylhydrazinderivaten.